Sales of its Vitrea 3-D visualization workstation helped Vital Images report sharply higher revenues for its first quarter (end-March), although the company’s net loss grew as well. For the period, the Minneapolis company posted sales of $766,000,
Sales of its Vitrea 3-D visualization workstation helped Vital Images report sharply higher revenues for its first quarter (end-March), although the companys net loss grew as well. For the period, the Minneapolis company posted sales of $766,000, compared with revenues of $156,000 in the first quarter of 1997. Vitrea began shipping in October, and in the most recent period contributed $488,000 to Vital Images revenues.
The companys net loss for the first quarter was $1.1 million, compared with a net loss of $873,000 for the first quarter of 1997. The net loss for the most recent period included a charge of $180,000 in connection with the departure of Vital Images former CEO, Andrew Weiss (SCAN 2/18/98).
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.